drug

Treatment-as-usual

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
OTHER
Pre-approval / investigational in the US
Developed by Ciusss de L'Est de l'Île de Montréal
2 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
OTHER

Indications

Trials

2
The Danish Region Midt Schizophrenia Cohort
NCT06431009—Recruiting
Virtual Reality Therapy for Treatment-resistant Auditory Hallucinations in Schizophrenia
NCT03148639—Completed

KOLs & investigators

1
Alexandre Dumais, MD, Ph.D

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Ciusss de L'Est de l'Île de Montréal
company
trial
The Danish Region Midt Schizophrenia Cohort
trial
Virtual Reality Therapy for Treatment-resistant Auditory Hallucinations in Schizophrenia
NA
trial
indication
Schizophrenia
indication
Treatment-resistant Schizophrenia
indication
Schizophrenia
indication
Schizophrenia, Treatment-Resistant
indication
KOL
Alexandre Dumais, MD, Ph.D
KOL score —
person